Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients

Due to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on perso...

Full description

Bibliographic Details
Main Authors: Zhenglin Chang, Rongqi Li, Jinhu Zhang, Lingyue An, Gaoxiang Zhou, Min Lei, Jiwang Deng, Riwei Yang, Zhenfeng Song, Wen Zhong, Defeng Qi, Xiaolu Duan, Shujue Li, Baoqing Sun, Wenqi Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008865/full
_version_ 1811257353867100160
author Zhenglin Chang
Zhenglin Chang
Zhenglin Chang
Rongqi Li
Jinhu Zhang
Lingyue An
Gaoxiang Zhou
Gaoxiang Zhou
Min Lei
Jiwang Deng
Riwei Yang
Zhenfeng Song
Zhenfeng Song
Wen Zhong
Defeng Qi
Xiaolu Duan
Shujue Li
Baoqing Sun
Wenqi Wu
Wenqi Wu
author_facet Zhenglin Chang
Zhenglin Chang
Zhenglin Chang
Rongqi Li
Jinhu Zhang
Lingyue An
Gaoxiang Zhou
Gaoxiang Zhou
Min Lei
Jiwang Deng
Riwei Yang
Zhenfeng Song
Zhenfeng Song
Wen Zhong
Defeng Qi
Xiaolu Duan
Shujue Li
Baoqing Sun
Wenqi Wu
Wenqi Wu
author_sort Zhenglin Chang
collection DOAJ
description Due to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on personalized immune and inflammatory characteristics. H&E-stained histopathology images confirmed the distinct infiltration of immune and inflammatory cells among clusters. Cluster-A was characterized by a favorable prognosis and low immune and inflammatory infiltration but showed the highest abundance of prognosis-related favorable immune cell and inflammatory activity. Cluster-B featured the worst prognosis and high immune infiltration, but numerous unfavorable immune cells exist. Cluster-C had a favorable prognosis and the highest immune and inflammatory infiltration. Based on machine learning, a highly precise predictive model (immune and inflammatory responses signature, IIRS), including FN1, IL10, MYC, CD247, and TLR2, was developed and validated to identify the high IIRS-score group that had a poor prognosis and advanced clinical characteristics. Compared to other published models, IIRS showed the highest AUC in 5 years of overall survival (OS) and a favorable predictive value in predicting 1- and 3- year OS. Moreover, IIRS showed an excellent performance in predicting immunotherapy and chemotherapy’s response. According to immunohistochemistry and qRT-PCR, IIRS genes were differentially expressed between tumor tissues with corresponding normal or adjacent tissues. Finally, immunohistochemical and H&E-stained analyses were performed on the bladder tissues of 13 BLCA patients to further demonstrate that the IIRS score is a valid substitute for IIR patterns and can contribute to identifying patients with poor clinical and histopathology characteristics. In conclusion, we established a novel IIRS depicting an IIR pattern that could independently predict OS and acts as a highly precise predictive biomarker for advanced clinical characters and the responses to immunotherapy and chemotherapy.
first_indexed 2024-04-12T17:56:03Z
format Article
id doaj.art-e793c3f461104d5599ea650a03e649bd
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T17:56:03Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e793c3f461104d5599ea650a03e649bd2022-12-22T03:22:21ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.10088651008865Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patientsZhenglin Chang0Zhenglin Chang1Zhenglin Chang2Rongqi Li3Jinhu Zhang4Lingyue An5Gaoxiang Zhou6Gaoxiang Zhou7Min Lei8Jiwang Deng9Riwei Yang10Zhenfeng Song11Zhenfeng Song12Wen Zhong13Defeng Qi14Xiaolu Duan15Shujue Li16Baoqing Sun17Wenqi Wu18Wenqi Wu19Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaDepartment of Allergy and Clinical Immunology, Department of Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Hepatobiliary Surgery, Foshan Hospital of Traditional Chinese Medical, Foshan, Guangdong, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Allergy and Clinical Immunology, Department of Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Allergy and Clinical Immunology, Department of Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDue to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on personalized immune and inflammatory characteristics. H&E-stained histopathology images confirmed the distinct infiltration of immune and inflammatory cells among clusters. Cluster-A was characterized by a favorable prognosis and low immune and inflammatory infiltration but showed the highest abundance of prognosis-related favorable immune cell and inflammatory activity. Cluster-B featured the worst prognosis and high immune infiltration, but numerous unfavorable immune cells exist. Cluster-C had a favorable prognosis and the highest immune and inflammatory infiltration. Based on machine learning, a highly precise predictive model (immune and inflammatory responses signature, IIRS), including FN1, IL10, MYC, CD247, and TLR2, was developed and validated to identify the high IIRS-score group that had a poor prognosis and advanced clinical characteristics. Compared to other published models, IIRS showed the highest AUC in 5 years of overall survival (OS) and a favorable predictive value in predicting 1- and 3- year OS. Moreover, IIRS showed an excellent performance in predicting immunotherapy and chemotherapy’s response. According to immunohistochemistry and qRT-PCR, IIRS genes were differentially expressed between tumor tissues with corresponding normal or adjacent tissues. Finally, immunohistochemical and H&E-stained analyses were performed on the bladder tissues of 13 BLCA patients to further demonstrate that the IIRS score is a valid substitute for IIR patterns and can contribute to identifying patients with poor clinical and histopathology characteristics. In conclusion, we established a novel IIRS depicting an IIR pattern that could independently predict OS and acts as a highly precise predictive biomarker for advanced clinical characters and the responses to immunotherapy and chemotherapy.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008865/fullbladder cancerchemotherapyimmunotherapyimmune and inflammatory characteristicsunsupervised cluster analysis
spellingShingle Zhenglin Chang
Zhenglin Chang
Zhenglin Chang
Rongqi Li
Jinhu Zhang
Lingyue An
Gaoxiang Zhou
Gaoxiang Zhou
Min Lei
Jiwang Deng
Riwei Yang
Zhenfeng Song
Zhenfeng Song
Wen Zhong
Defeng Qi
Xiaolu Duan
Shujue Li
Baoqing Sun
Wenqi Wu
Wenqi Wu
Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
Frontiers in Immunology
bladder cancer
chemotherapy
immunotherapy
immune and inflammatory characteristics
unsupervised cluster analysis
title Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
title_full Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
title_fullStr Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
title_full_unstemmed Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
title_short Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
title_sort distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
topic bladder cancer
chemotherapy
immunotherapy
immune and inflammatory characteristics
unsupervised cluster analysis
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008865/full
work_keys_str_mv AT zhenglinchang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT zhenglinchang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT zhenglinchang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT rongqili distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT jinhuzhang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT lingyuean distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT gaoxiangzhou distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT gaoxiangzhou distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT minlei distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT jiwangdeng distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT riweiyang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT zhenfengsong distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT zhenfengsong distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT wenzhong distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT defengqi distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT xiaoluduan distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT shujueli distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT baoqingsun distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT wenqiwu distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients
AT wenqiwu distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients